It has been demonstrated that Tim-3 is over-expressed on T-cells of several solid and hematological malignancies (Sakuishi et al., 2010; Riches et al., 2013; Hadadi et al., 2019). The gene discussed is HAVCR2; the disease is hematologic disorder.